However, the inability to inhibit all anti‐apoptotic proteins, in particular Mcl‐1, has been shown to result in drug resistance.7a Despite being one of the most frequently amplified genes in cancer and being a major factor in resistance to chemotherapy, Mcl‐1 has proven the most elusive, with no candidates currently in clinical trial. This evidence concerns the gene MCL1 and cancer.